ACAD
ACAD
NASDAQ · Biotechnology

Acadia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$20.96
-0.03 (-0.14%)
As of Mar 24, 9:56 PM ET ·
Analyst Consensus
Buy
27
Analysts
High
Coverage
Buy 20 74%
Hold 6 22%
Sell 1 4%
Price Target
Analyst Price Target -14.6% upside
Low Target $12.70
Average Target $17.90
High Target $23.84
Current Price $20.96
Current
$20.96
Target
$17.90
$12.70 $17.90 avg $23.84
Scenario Analysis
Bear Case
$12.70
-39.4%
Low target
Base Case
$17.90
-14.6%
Avg target
Bull Case
$23.84
+13.7%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$28.35
-26.1% from high
52-Week Low
$13.40
+56.4% from low
50-Day SMA
$25.91
-19.1% vs SMA
200-Day SMA
$23.44
-10.6% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$17.90
-36.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%